Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
Thursday, May 06, 2021 9:29:45 AM
Can't disagree with anything you posted. (My thoughts 2-cents in red.)
"My post had nothing to do with a individuals choice of being vaccinated or not. Your body, your choice." (Oh, how conveinent for some that when the object of the debate changes, you can tell me what to do! A correlary to "What is mine, is mine, what is yours is mine!")
"No matter how you want to digest the numbers 35% of the new cases are those vaccinated is not a insignificant number." IMO VERY SIGNIFICANT.
"The last few PRs have stated that researchers have been doing extensive work involving BRILACIDIN. It would indicate to me that the initial lab studies never stopped, have been running continuously since and are still on going." (LEO's PR have continuously run a thread regarding RBL reseach, continuing and expanding, both deeper into Covid1-9 AND BROADER into Pan-coronavirus/Alpha-viruses...one just needs to READ and believe in the veracity of the statements...which SUBSTANCE have ALL PROVEN OUT...timing not in his control )
"The researchers have obviously seen something that has caught their interest." (IMO have seen something SIGNIFICANT in BRILACIDIN...just because IPIX does not receive grants for Brilacidin does not mean RBL's and others don't receive GRANTS WHICH INCORPORATE FURTHER RESEARCH into the potential efficacy of Brilacidin for Pan-coronavirus/Alpha-viruses...which was noted in yesterday's letter to Shareholder)
"My post was for the hope that BRILACIDIN can be formulated for use as a inhaler after the upcoming successful phase 2 CV trials." (Agreed...but detractors of LEO, IPIX and BRILACIDIN...will use raising funds for that purpose as a weapon against all three..."Oh no...more dilution!" Big F'n deal ... I'm with you on it...the multiple will just get larger...Dilution is a straw-man. Getting multiple dollars more in valuation because of inhaler...will pay off in spades)
"The successful trial should bring grants, government funds, partnerships, something of monetary significance to move BRILACIDIN and IPIX forward."...(and of course EUA...and LICENSING!)
"My wish is for BRILACIDIN SI *426* to be available to everyone in a variety of forms. The quicker the better. The fact is Covid isn't going anywhere anytime soon. A BRILACIDIN nebulizer would be a great help to both the vaccinated and unvaccinated. Both will need that option." (Agreed!).
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM